Casticin induces ovarian cancer cell apoptosis by repressing FoxM1 through the activation of FOXO3a

Induction of apoptosis by casticin in cervical cancer cells: reactive oxygen species-dependent sustained activation of Jun N-terminal kinase

(2012) F. Zeng et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb

(2012) Christin F. Down et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

The FOXM1-PLK1 axis is commonly upregulated in oesophageal adenocarcinoma

(2012) M Dibb et al.   BRITISH JOURNAL OF CANCER

A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

(2012) Gordana Vlahovic et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

FOXM1 is a molecular determinant of the mitogenic and invasive phenotype of anaplastic thyroid carcinoma

(2012) Roberto Bellelli et al.   ENDOCRINE-RELATED CANCER

Differential expression of forkhead box M1 and its downstream cyclin-dependent kinase inhibitors p27kip1 and p21waf1/cip1 in the diagnosis of pulmonary neuroendocrine tumours

(2012) Seung Yeon Ha et al.   HISTOPATHOLOGY

Aberrant Expression of WWOX Protein in Epithelial Ovarian Cancer

(2012) Chao Lan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Suppression of FOXM1 Sensitizes Human Cancer Cells to Cell Death Induced by DNA-Damage

(2012) Marianna Halasi et al.   PLoS One

An Aqueous Extract of Fagonia cretica Induces DNA Damage, Cell Cycle Arrest and Apoptosis in Breast Cancer Cells via FOXO3a and p53 Expression

(2012) Matt Lam et al.   PLoS One

FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner

(2011) Jamila Laoukili et al.   CELL CYCLE

FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy

(2011) Miranda S.C. Wilson et al.   CURRENT DRUG TARGETS

ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance

(2011) J. Millour et al.   MOLECULAR CANCER THERAPEUTICS

Integrated genomic analyses of ovarian carcinoma

(2011) D. Bell et al.   NATURE

Casticin-induced apoptosis involves death receptor 5 upregulation in hepatocellular carcinoma cells

(2011) Jun Yang   WORLD JOURNAL OF GASTROENTEROLOGY

Negative regulation of the oncogenic transcription factor FoxM1 by thiazolidinediones and mithramycin

(2010) Vladimir Petrovic et al.   CANCER BIOLOGY & THERAPY

Understanding FOXO, New Views on Old Transcription Factors

(2010) F. Zanella et al.   CURRENT CANCER DRUG TARGETS

FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells

(2010) J. M.-M. Kwok et al.   MOLECULAR CANCER RESEARCH

Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy

(2010) Liang Fang et al.   ORAL ONCOLOGY

FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer

(2010) Zhiwei Wang et al.   PHARMACEUTICAL RESEARCH

Ovarian cancer

(2009) Bryan T Hennessy et al.   LANCET

Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer

(2009) U. B. McGovern et al.   MOLECULAR CANCER THERAPEUTICS

The evolution of Fox genes and their role in development and disease

(2009) Sridhar Hannenhalli et al.   NATURE REVIEWS GENETICS

Cytotoxic effects of flavonoids against a human colon cancer derived cell line, COLO 201: A potential natural anti-cancer substance

(2008) Masahiko Imai et al.   CANCER LETTERS

Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression

(2008) J. M-M. Kwok et al.   MOLECULAR CANCER THERAPEUTICS

Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression

(2008) Zheng Fu et al.   NATURE CELL BIOLOGY

Interaction of major genes predisposing to hepatocellular carcinoma with genes encoding signal transduction pathways influences tumor phenotype and prognosis

(2008) Francesco Feo et al.   WORLD JOURNAL OF GASTROENTEROLOGY